Pages that link to "Q40373479"
Jump to navigation
Jump to search
The following pages link to Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone (Q40373479):
Displaying 50 items.
- Cytochrome P4502C9: an enzyme of major importance in human drug metabolism (Q24683497) (← links)
- Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol (Q28288315) (← links)
- An in vitro study of drug displacement interactions: warfarin-salicylate and warfarin-phenylbutazone (Q28317383) (← links)
- Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man (Q28367057) (← links)
- Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. (Q34183067) (← links)
- American Heart Association/American College of Cardiology Foundation guide to warfarin therapy (Q34196283) (← links)
- Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (Q34252907) (← links)
- Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models (Q34276559) (← links)
- Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin (Q34346399) (← links)
- Effect of naproxen on glucose metabolism and tolbutamide kinetics and dynamics in maturity onset diabetics (Q34448589) (← links)
- Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction (Q34512146) (← links)
- Enhanced elimination of warfarin during treatment with cholestyramine (Q34516501) (← links)
- Drug interactions with warfarin enantiomers--a different perspective (Q34517283) (← links)
- Stereoselective renal clearance of pindolol in humans (Q34563398) (← links)
- Evaluation of a potential tigecycline-warfarin drug interaction (Q34593514) (← links)
- Progress in clinical pharmacology over the last 20 years (Q35130802) (← links)
- Drug interactions: Part I (Q36138026) (← links)
- Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics (Q36330247) (← links)
- Microbial transformations of warfarin: stereoselective reduction by Nocardia corallina and Arthrobacter species. (Q36707898) (← links)
- LC-MS-MS Analysis of Brodifacoum Isomers in Rat Tissue (Q36806032) (← links)
- Chiral stereoisomeric molecules in the treatment of arthritis (Q36820837) (← links)
- The Problems of Using NSAIDs in the Elderly (Q36916769) (← links)
- The Problems and Pitfalls of NSAID Therapy in the Elderly (Part II)1 (Q36972832) (← links)
- Applying organ clearance concepts in a clinical setting (Q37070779) (← links)
- Pharmacogenetics of oral anticoagulants: a basis for dose individualization (Q37242614) (← links)
- Molecular asymmetry and its pharmacological consequences (Q37544345) (← links)
- Clinical features and management of adverse effects of quinolone antibacterials (Q37713472) (← links)
- Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know (Q37863679) (← links)
- Carbonyl reduction pathways in drug metabolism. (Q38156452) (← links)
- Protein binding drug displacement interactions fact or fiction? (Q38631251) (← links)
- Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy (Q38631282) (← links)
- Phenylbutazone-warfarin interaction in the dog (Q39068702) (← links)
- Biliary excretion of warfarin metabolites and their metabolism by rat gut flora (Q39132597) (← links)
- Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats (Q39151860) (← links)
- Drug interactions and lethal drug combinations (Q39395477) (← links)
- Stereoselectivity: an issue of significant importance in clinical pharmacology (Q39529348) (← links)
- Drug interactions that matter. A critical reappraisal (Q39554942) (← links)
- The basis for variability of response to anti-rheumatic drugs (Q39560477) (← links)
- Protein Binding of Coumarin Anticoagulants in Disease States (Q39622793) (← links)
- Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs (Q39662377) (← links)
- Aspects of anticoagulant action: a review of the pharmacology, metabolism and toxicology of warfarin and congeners (Q39705808) (← links)
- Interindividual Differences in the Response to Oral Anticoagulants (Q39712322) (← links)
- Clinical Pharmacokinetics of Phenylbutazone (Q39773902) (← links)
- Clinical Pharmacokinetics of Oral Anticoagulants (Q39787840) (← links)
- Importance of drug enantiomers in clinical pharmacology (Q39834900) (← links)
- On chiral drug action (Q40076893) (← links)
- Clinical Implications of Enzyme Induction and Enzyme Inhibition (Q40084496) (← links)
- Interaction between Oral Anti-Coagulant Drugs and Non-Steroidal Anti-Inflammatory Agents: A Review (Q40146875) (← links)
- Protein binding displacement interactions and their clinical importance (Q40151099) (← links)
- Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs (Q40157661) (← links)